COVID-19 Impact on Hyaluronic Acid for Osteoarthritis Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Hyaluronic Acid for Osteoarthritis Industry
1.7 COVID-19 Impact: Hyaluronic Acid for Osteoarthritis Market Trends
2 Global Hyaluronic Acid for Osteoarthritis Quarterly Market Size Analysis
2.1 Hyaluronic Acid for Osteoarthritis Business Impact Assessment - COVID-19
2.1.1 Global Hyaluronic Acid for Osteoarthritis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Hyaluronic Acid for Osteoarthritis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Hyaluronic Acid for Osteoarthritis Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Hyaluronic Acid for Osteoarthritis Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Hyaluronic Acid for Osteoarthritis Factory Price by Manufacturers
3.3 Location of Key Manufacturers Hyaluronic Acid for Osteoarthritis Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Hyaluronic Acid for Osteoarthritis Market
3.5 Key Manufacturers Hyaluronic Acid for Osteoarthritis Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Hyaluronic Acid for Osteoarthritis Segments, By Type
4.1 Introduction
1.4.1 Single Injection
1.4.2 Three Injection
1.4.3 Five Injection
4.2 By Type, Global Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021
4.2.1 By Type, Global Hyaluronic Acid for Osteoarthritis Market Size by Type, 2020-2021
4.2.2 By Type, Global Hyaluronic Acid for Osteoarthritis Price, 2020-2021
5 Impact of Covid-19 on Hyaluronic Acid for Osteoarthritis Segments, By Application
5.1 Overview
5.5.1 knee joint
5.5.2 hip joint
5.5.3 shoulder joint
5.5.4 ankle joint
5.5.5 Others
5.2 By Application, Global Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021
5.2.1 By Application, Global Hyaluronic Acid for Osteoarthritis Market Size by Application, 2019-2021
5.2.2 By Application, Global Hyaluronic Acid for Osteoarthritis Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 BIOVENTUS
7.1.1 BIOVENTUS Business Overview
7.1.2 BIOVENTUS Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.1.3 BIOVENTUS Hyaluronic Acid for Osteoarthritis Product Introduction
7.1.4 BIOVENTUS Response to COVID-19 and Related Developments
7.2 sanofi-aventis
7.2.1 sanofi-aventis Business Overview
7.2.2 sanofi-aventis Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.2.3 sanofi-aventis Hyaluronic Acid for Osteoarthritis Product Introduction
7.2.4 sanofi-aventis Response to COVID-19 and Related Developments
7.3 Ferring B.V.
7.3.1 Ferring B.V. Business Overview
7.3.2 Ferring B.V. Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.3.3 Ferring B.V. Hyaluronic Acid for Osteoarthritis Product Introduction
7.3.4 Ferring B.V. Response to COVID-19 and Related Developments
7.4 Anika Therapeutics
7.4.1 Anika Therapeutics Business Overview
7.4.2 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.4.3 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Product Introduction
7.4.4 Anika Therapeutics Response to COVID-19 and Related Developments
7.5 Fidia Farma
7.5.1 Fidia Farma Business Overview
7.5.2 Fidia Farma Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.5.3 Fidia Farma Hyaluronic Acid for Osteoarthritis Product Introduction
7.5.4 Fidia Farma Response to COVID-19 and Related Developments
7.6 LG Chem
7.6.1 LG Chem Business Overview
7.6.2 LG Chem Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.6.3 LG Chem Hyaluronic Acid for Osteoarthritis Product Introduction
7.6.4 LG Chem Response to COVID-19 and Related Developments
7.7 Bohus BioTech
7.7.1 Bohus BioTech Business Overview
7.7.2 Bohus BioTech Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.7.3 Bohus BioTech Hyaluronic Acid for Osteoarthritis Product Introduction
7.7.4 Bohus BioTech Response to COVID-19 and Related Developments
7.8 Hangzhou Singclean Medical Products
7.8.1 Hangzhou Singclean Medical Products Business Overview
7.8.2 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.8.3 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Product Introduction
7.8.4 Hangzhou Singclean Medical Products Response to COVID-19 and Related Developments
7.9 Biolevox
7.9.1 Biolevox Business Overview
7.9.2 Biolevox Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.9.3 Biolevox Hyaluronic Acid for Osteoarthritis Product Introduction
7.9.4 Biolevox Response to COVID-19 and Related Developments
7.10 Vivacy
7.10.1 Vivacy Business Overview
7.10.2 Vivacy Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.10.3 Vivacy Hyaluronic Acid for Osteoarthritis Product Introduction
7.10.4 Vivacy Response to COVID-19 and Related Developments
7.11 ideolab
7.11.1 ideolab Business Overview
7.11.2 ideolab Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.11.3 ideolab Hyaluronic Acid for Osteoarthritis Product Introduction
7.11.4 ideolab Response to COVID-19 and Related Developments
7.12 Xediton Pharmaceuticals
7.12.1 Xediton Pharmaceuticals Business Overview
7.12.2 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.12.3 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Product Introduction
7.12.4 Xediton Pharmaceuticals Response to COVID-19 and Related Developments
7.13 Deka
7.13.1 Deka Business Overview
7.13.2 Deka Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.13.3 Deka Hyaluronic Acid for Osteoarthritis Product Introduction
7.13.4 Deka Response to COVID-19 and Related Developments
7.14 BIOIBERICA
7.14.1 BIOIBERICA Business Overview
7.14.2 BIOIBERICA Hyaluronic Acid for Osteoarthritis Quarterly Production and Revenue, 2020
7.14.3 BIOIBERICA Hyaluronic Acid for Osteoarthritis Product Introduction
7.14.4 BIOIBERICA Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Hyaluronic Acid for Osteoarthritis Supply Chain Analysis
8.1.1 Hyaluronic Acid for Osteoarthritis Supply Chain Analysis
8.1.2 Covid-19 Impact on Hyaluronic Acid for Osteoarthritis Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Hyaluronic Acid for Osteoarthritis Distribution Channels
8.2.2 Covid-19 Impact on Hyaluronic Acid for Osteoarthritis Distribution Channels
8.2.3 Hyaluronic Acid for Osteoarthritis Distributors
8.3 Hyaluronic Acid for Osteoarthritis Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Hyaluronic Acid for Osteoarthritis Assessment
Table 9. COVID-19 Impact: Hyaluronic Acid for Osteoarthritis Market Trends
Table 10. COVID-19 Impact Global Hyaluronic Acid for Osteoarthritis Market Size
Table 11. Global Hyaluronic Acid for Osteoarthritis Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Hyaluronic Acid for Osteoarthritis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Hyaluronic Acid for Osteoarthritis Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Hyaluronic Acid for Osteoarthritis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Hyaluronic Acid for Osteoarthritis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Hyaluronic Acid for Osteoarthritis Market Growth Drivers
Table 17. Global Hyaluronic Acid for Osteoarthritis Market Restraints
Table 18. Global Hyaluronic Acid for Osteoarthritis Market Opportunities
Table 19. Global Hyaluronic Acid for Osteoarthritis Market Challenges
Table 20. Key Manufacturers Hyaluronic Acid for Osteoarthritis Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Hyaluronic Acid for Osteoarthritis Market Size, 2019 (K Units) & (US$ Million)
Table 22. Hyaluronic Acid for Osteoarthritis Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Hyaluronic Acid for Osteoarthritis Manufacturing Plants
Table 24. Key Manufacturers Hyaluronic Acid for Osteoarthritis Market Served
Table 25. Date of Key Manufacturers Enter into Hyaluronic Acid for Osteoarthritis Market
Table 26. Key Manufacturers Hyaluronic Acid for Osteoarthritis Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hyaluronic Acid for Osteoarthritis Market Size by Type, 2020, (US$ Million)
Table 29. Global Hyaluronic Acid for Osteoarthritis Market Size by Type, 2020 (K Units)
Table 30. Global Hyaluronic Acid for Osteoarthritis Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Hyaluronic Acid for Osteoarthritis Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Hyaluronic Acid for Osteoarthritis Market Size by Application, 2020-2021 (K Units)
Table 33. Global Hyaluronic Acid for Osteoarthritis Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Hyaluronic Acid for Osteoarthritis Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Hyaluronic Acid for Osteoarthritis Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (K Units)
Table 38. US Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (K Units)
Table 43. Germany Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (K Units)
Table 50. China Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. BIOVENTUS Business Overview
Table 58. BIOVENTUS Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. BIOVENTUS Hyaluronic Acid for Osteoarthritis Product
Table 60. BIOVENTUS Response to COVID-19 and Related Developments
Table 61. sanofi-aventis Business Overview
Table 62. sanofi-aventis Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. sanofi-aventis Hyaluronic Acid for Osteoarthritis Product
Table 64. sanofi-aventis Response to COVID-19 and Related Developments
Table 65. Ferring B.V. Business Overview
Table 66. Ferring B.V. Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Ferring B.V. Hyaluronic Acid for Osteoarthritis Product
Table 68. Ferring B.V. Response to COVID-19 and Related Developments
Table 69. Anika Therapeutics Business Overview
Table 70. Anika Therapeutics Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Anika Therapeutics Hyaluronic Acid for Osteoarthritis Product
Table 72. Anika Therapeutics Response to COVID-19 and Related Developments
Table 73. Fidia Farma Business Overview
Table 74. Fidia Farma Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Fidia Farma Hyaluronic Acid for Osteoarthritis Product
Table 76. Fidia Farma Response to COVID-19 and Related Developments
Table 77. LG Chem Business Overview
Table 78. LG Chem Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. LG Chem Hyaluronic Acid for Osteoarthritis Product
Table 80. LG Chem Response to COVID-19 and Related Developments
Table 81. Bohus BioTech Business Overview
Table 82. Bohus BioTech Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bohus BioTech Hyaluronic Acid for Osteoarthritis Product
Table 84. Bohus BioTech Response to COVID-19 and Related Developments
Table 85. Hangzhou Singclean Medical Products Business Overview
Table 86. Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Product
Table 88. Hangzhou Singclean Medical Products Response to COVID-19 and Related Developments
Table 89. Biolevox Business Overview
Table 90. Biolevox Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Biolevox Hyaluronic Acid for Osteoarthritis Product
Table 92. Biolevox Response to COVID-19 and Related Developments
Table 93. Vivacy Business Overview
Table 94. Vivacy Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Vivacy Hyaluronic Acid for Osteoarthritis Product
Table 96. Vivacy Response to COVID-19 and Related Developments
Table 97. ideolab Business Overview
Table 98. ideolab Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. ideolab Hyaluronic Acid for Osteoarthritis Product
Table 100. ideolab Response to COVID-19 and Related Developments
Table 101. Xediton Pharmaceuticals Business Overview
Table 102. Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Product
Table 104. Xediton Pharmaceuticals Response to COVID-19 and Related Developments
Table 105. Deka Business Overview
Table 106. Deka Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Deka Hyaluronic Acid for Osteoarthritis Product
Table 108. Deka Response to COVID-19 and Related Developments
Table 109. BIOIBERICA Business Overview
Table 110. BIOIBERICA Hyaluronic Acid for Osteoarthritis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. BIOIBERICA Hyaluronic Acid for Osteoarthritis Product
Table 112. BIOIBERICA Response to COVID-19 and Related Developments
Table 113. Hyaluronic Acid for Osteoarthritis Distributors List
Table 114. Hyaluronic Acid for Osteoarthritis Customers List
Table 115. Covid-19 Impact on Hyaluronic Acid for Osteoarthritis Customers
List of FiguresFigure 1. Hyaluronic Acid for Osteoarthritis Product Picture
Figure 2. Hyaluronic Acid for Osteoarthritis Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Hyaluronic Acid for Osteoarthritis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Hyaluronic Acid for Osteoarthritis Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Hyaluronic Acid for Osteoarthritis Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Hyaluronic Acid for Osteoarthritis Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Hyaluronic Acid for Osteoarthritis Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Hyaluronic Acid for Osteoarthritis Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Hyaluronic Acid for Osteoarthritis Market Size Market Share, 2019-2021